Your browser doesn't support javascript.
loading
Biomedical applications of L-alanine produced by Pediococcus acidilactici BD16 (alaD+).
Sharma, Anshula; Mehta, Vikrant; Rani, Suman; Noda, Masafumi; Sugiyama, Masanori; Chander, Harish; Kaur, Baljinder.
Afiliación
  • Sharma A; Systems Biology Laboratory, Department of Biotechnology, Punjabi University, Patiala, 147002, India.
  • Mehta V; Laboratory of Molecular Medicine, Department of Human Genetics and Molecular Medicine, Central University of Punjab, Bathinda, 151401, India.
  • Rani S; Genetic Engineering Laboratory, Department of Biotechnology, Punjabi University, Patiala, 147002, India.
  • Noda M; Graduate School of Biomedical and Health Sciences, Hiroshima University, Kasumi, Minami-ku, Hiroshima, 734-8553, Japan.
  • Sugiyama M; Graduate School of Biomedical and Health Sciences, Hiroshima University, Kasumi, Minami-ku, Hiroshima, 734-8553, Japan.
  • Chander H; Systems Biology Laboratory, Department of Biotechnology, Punjabi University, Patiala, 147002, India.
  • Kaur B; Bio-Therapeutics Division, National Institute of Biologicals, Noida, 201309, India.
Appl Microbiol Biotechnol ; 106(4): 1435-1446, 2022 Feb.
Article en En | MEDLINE | ID: mdl-35089399
ABSTRACT
L-alanine possesses extensive physiological functionality and tremendous pharmacological significance, therefore could be considered as potential ingredient for food, pharmaceutical, and personal care products. However, therapeutic properties of L-alanine still need to be addressed in detail to further strengthen its utilization as a viable ingredient for developing natural therapeutics with minimum side effects. Thus, the present study was aimed to explore the anticipated therapeutic potential of L-alanine, produced microbially using a lactic acid bacterial strain Pediococcus acidilactici BD16 (alaD+) expressing L-alanine dehydrogenase enzyme. The anticipated therapeutic potential of L-alanine was assessed in terms of anti-proliferative, anti-bacterial, and anti-urolithiatic properties. Anti-bacterial assays revealed that L-alanine successfully inhibited growth and in vitro proliferation of important human pathogens including Enterococcus faecalis, Escherichia coli, Klebsiella pneumonia, Staphylococcus aureus, Streptococcus mutans, and Vibrio cholerae in a concentration-dependent manner. Current investigation has also revealed its significant anti-proliferative potential against human lung adenocarcinoma (A549; IC50 7.32 µM) and mammary gland adenocarcinoma (MCF-7; IC50 8.81 µM) cells. The anti-urolithiatic potential of L-alanine was augmented over three different phases, viz., nucleation inhibition, aggregation inhibition, and oxalate depletion. Further, an in vitro cell culture-based kidney stone dissolution model using HEK293-T cells was also established to further strengthen its anti-urolithiatic potential. This is probably the first in vitro cell culture-based model which experimentally validates the immense therapeutic efficacy of L-alanine in treating urolithiasis disease. KEY POINTS • Assessment of therapeutic potential of L-alanine produced by LAB. • L-alanine exhibited significant anti-proliferative and anti-bacterial activities. • L-alanine as potential anti-urolithiatic agent.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pediococcus acidilactici Límite: Humans Idioma: En Revista: Appl Microbiol Biotechnol Año: 2022 Tipo del documento: Article País de afiliación: India

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pediococcus acidilactici Límite: Humans Idioma: En Revista: Appl Microbiol Biotechnol Año: 2022 Tipo del documento: Article País de afiliación: India